Published in Infect Immun on October 01, 1982
Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect Immun (1983) 0.99
Killed Listeria-induced suppressor T cells involved in suppression of delayed-type hypersensitivity and protection against Listeria infection. Immunology (1985) 0.82
Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide. Infect Immun (1983) 0.78
Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives. Infect Immun (1985) 0.75
Cellular and molecular investigations of the adhesion and mechanics of Listeria monocytogenes lineages' I and II environmental and epidemic strains. J Colloid Interface Sci (2012) 0.75
Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev (1972) 19.14
Plaque Formation in Agar by Single Antibody-Producing Cells. Science (1963) 10.20
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1974) 6.53
Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells. Cell Immunol (1971) 6.16
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
Primary immune response in cultures of spleen cells. Lancet (1967) 5.64
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology (1970) 4.25
Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J (1975) 3.69
Listeria cell wall fraction: a B cell mitogen. J Immunol (1975) 1.94
Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun (1974) 1.82
Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. J Immunol (1974) 1.79
Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds. Infect Immun (1976) 1.70
Induction of Resistance by Listeria monocytogenes Cell Wall Fraction. Infect Immun (1974) 1.48
Immunochemistry of the cell walls of Listeria monocytogenes. J Bacteriol (1969) 1.42
Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. J Biochem (1982) 1.18
Isolation, characterization, and biological properties of an endotoxin-like material from the gram-positive organism Listeria monocytogenes. Infect Immun (1979) 1.18
Listeria cell wall fraction: a B cell adjuvant. J Immunol (1976) 1.16
Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes. J Natl Cancer Inst (1974) 1.01
Listeria cell wall fraction: adjuvant activity in vivo and in vitro. Cell Immunol (1975) 1.00
The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity. Cell Immunol (1979) 1.00
Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. J Natl Cancer Inst (1975) 0.99
Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma. J Natl Cancer Inst (1975) 0.99
Heat-labile B-cell mitogen obtained from Listeria monocytogenes. Infect Immun (1978) 0.96
Adjuvant and antitumor activities of Nocardia cell-wall skeletons. Gan (1976) 0.93
Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829. Jpn J Microbiol (1975) 0.92
Use of a macrophage cytotoxicity system to show macrophage activation by Listeria monocytogenes cell wall fraction. Scand J Immunol (1979) 0.89
STUDIES ON ENZYME-ANTIENZYME SYSTEMS. II. N-BROMOSUCCINIMIDE MODIFIED BACTERIAL ALPHA-AMYLASE. J Biochem (1963) 0.87
Antitumor activity of Listeria monocytogenes on a guinea pig fibrosarcoma. Infect Immun (1979) 0.85
Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice. Jpn J Microbiol (1975) 0.83
Adjuvant activity of mycobacterial fractions. II. In vitro adjuvant activity of cell walls of mycobacteria, nocardia and corynebacteria. Jpn J Microbiol (1974) 0.82
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res (1982) 4.98
T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol (1981) 2.46
Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol (1982) 2.26
Simple, rapid, quantitative, and sensitive detection of telomere repeats in cell lysate by a hybridization protection assay. Clin Chem (1999) 2.11
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors. Infect Immun (2000) 2.10
Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax (1998) 2.04
Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol (1999) 1.86
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation (2001) 1.86
Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull (1995) 1.85
Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol (2001) 1.85
Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst (1974) 1.82
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res (1999) 1.82
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol (1996) 1.80
Chemical and immunological properties of galactomannans obtained from Histoplasma duboisii, Histoplasma capsulatum, Paracoccidioides brasiliensis and Blasomyces dermatitidis. Mycopathol Mycol Appl (1974) 1.77
Biochemical studies on the thermal dimorphism of Paracoccidioides brasiliensis. J Bacteriol (1972) 1.76
Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli. J Bacteriol (1968) 1.74
B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med (1983) 1.73
Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta (1970) 1.73
An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg (1998) 1.71
Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds. Infect Immun (1976) 1.70
Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun (1991) 1.67
Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J Biochem (1977) 1.66
Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin. Cell Immunol (1975) 1.65
In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells. J Immunol (1977) 1.61
Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. J Immunol (1983) 1.57
Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur J Immunol (2001) 1.56
Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol (1986) 1.55
Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun (1976) 1.55
Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. J Immunol (1975) 1.53
Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem (1992) 1.52
Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer (1993) 1.52
Cloning of the Membrane-Bound Aldehyde Dehydrogenase Gene of Acetobacter polyoxogenes and Improvement of Acetic Acid Production by Use of the Cloned Gene. Appl Environ Microbiol (1989) 1.52
Cloning and sequencing of the gene cluster encoding two subunits of membrane-bound alcohol dehydrogenase from Acetobacter polyoxogenes. Biochim Biophys Acta (1991) 1.51
Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol (1999) 1.49
Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci U S A (1981) 1.48
An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun (1998) 1.47
In vitro antibody formation by human tonsil lymphocytes. J Immunol (1974) 1.47
Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty. Eur Heart J (2000) 1.47
Low wear rate of UHMWPE against zirconia ceramic (Y-PSZ) in comparison to alumina ceramic and SUS 316L alloy. J Biomed Mater Res (1991) 1.46
The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. Immunology (1975) 1.45
A case of Takayasu's arteritis associated with membranoproliferative glomerulonephritis and nephrotic syndrome. Nephron (1990) 1.43
Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet (1997) 1.43
Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival. J Am Coll Surg (1996) 1.43
Structural studies on teichoic acids in cell walls of several serotypes of Listeria monocytogenes. J Biochem (1986) 1.42
Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. J Natl Cancer Inst (1974) 1.42
The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer (1996) 1.41
Chemical and ultrastructural studies on the cell walls of the yeastlike and mycelial forms of Histoplasma capsulatum. Mycopathol Mycol Appl (1974) 1.41
Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol (1997) 1.40
Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect. Bone Marrow Transplant (2006) 1.39
Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst (1974) 1.38
Constituents of the Vietnamese medicinal plant Orthosiphon stamineus. Chem Pharm Bull (Tokyo) (2000) 1.38
Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair. Am Ind Hyg Assoc J (1989) 1.37
Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II). J Immunol (1985) 1.34
Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol (1993) 1.33
Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology (1973) 1.32
n-Hexane polyneuropathy. Folia Psychiatr Neurol Jpn (1969) 1.31
IgE class-specific suppressor T cells and factors in humans. J Immunol (1983) 1.31
Functional V region formation during in vitro culture of a murine immature B precursor cell line. Nature (1983) 1.30
Structural and immunochemical studies of teichoic acid of Listeria monocytogenes. J Biochem (1983) 1.29
Papain fragmentation of the subunits of human macroglobulin. J Immunol (1967) 1.29
Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases. Neurology (1971) 1.28
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem (1999) 1.28
Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas. J Natl Cancer Inst (1975) 1.28
Regulation of antibody response in different immunoglobulin classes. V. Establishment of T hybrid cell line secreting IgE class-specific suppressor factor. J Immunol (1978) 1.26
Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull (1994) 1.26
Standardization of lymphocyte transformation to Candida immunogen. Clin Exp Immunol (1974) 1.25
Biochemical and immunological studies on Aspergillus. 3. Chemical and immunological properties of glycopeptide obtained from Aspergillus fumigatus. Jpn J Microbiol (1971) 1.24
[Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)]. Nippon Ganka Gakkai Zasshi (1981) 1.24
Further purification of polysaccharides having anaphylactic activity from culture filtrate of human tubercle bacilli. Am Rev Respir Dis (1967) 1.24
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Am J Gastroenterol (1996) 1.22
A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg (1997) 1.22
Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol (1995) 1.22
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology (2004) 1.22
Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus (2006) 1.21
Antibody production in mice. I. The analysis of immunological memory. Immunology (1969) 1.21
Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev (2001) 1.21
Incidence, diagnosis and significance of multiple gastric cancer. Br J Surg (1995) 1.20
Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis. Cell Immunol (1975) 1.20
Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br J Cancer (1999) 1.20
Immunological activity of chitin and its derivatives. Vaccine (1984) 1.19
Depressed immunological defence mechanisms in mice with experimentally induced diabetes. Infect Immun (1980) 1.18